Mabwell and Yuanxin Technology Cooperate to Establish a Comprehensive Innovative Marketing Model

Release time:Sep 09, 2022

Mabwell (stock code: 688062.SH), an innovative biopharmaceutical company with the layout of the whole industry chain, announced a strategic cooperation with Beijing Yuanxin Technology Group Co., Ltd. ("Yuanxin Technology") on September 9, 2022, with the vision to work together to jointly explore a comprehensive marketing model integrating online and offline channels. On the same day, Dr. Liu Datao, co-founder and CEO of Mabwell, and Mr. Luo Dongtao, co-president of Yuanxin Technology, formally signed a memorandum of strategic cooperation in Beijing by online and offline meetings.

Based on the advantages and experience of Yuanxin Technology's online hospital, offline pharmacy, commercial medical insurance, novel design of payment process, and management and operation, Mabwell negotiated about in-depth cooperation and signed strategic cooperation agreements with Yuanxin Technology, to provide physicians and patients with hospital and out-of-hospital linkage solutions, allowing patients to timely use safe and affordable innovative drugs, and provide innovative solutions to serve their diverse medical needs. Taking their respective resources and professional advantages as complementary in future cooperation, both parties will jointly explore novel payment models for innovative pharmaceutical products and improve patients' access to drugs.

20220910141433118994.png

Dr. Liu Datao, co-founder and CEO of Mabwell, said that "Self-reliance and self-improvement in science and technology is the strategic support for national development, and biomedicine is one of the key directions of the 14th Five-Year Plan. Mabwell adheres to patient-centered, science-led, innovation-driven practices, focuses on the disease field, and is committed to provide more effective and accessible therapy and innovative medicines to fulfill global medical needs. Under the background of the digital era, physicians and patients have more and more access to medical information, following ever-growing demands for medical quality. Through strategic cooperation with Yuanxin Technology, an excellent Internet medical technology company, not only can the accessibility of medical services be further improved, but also more innovative solutions can be provided for physicians, patients and industry parties. With the strong allies, we hope to reach mutual wins."

Mr. Luo Dongtao, co-president of Yuanxin Technology, said that "Exploring novel medical payment methods and improving patients' access to drugs is a hot topic in recent years. As a healthcare company, Yuanxin Technology is dedicated to develop novel payment solutions to reduce patients' burden, allowing those in need to gain access to more effective innovative and specific drugs and improve treatment outcomes. Meanwhile, improvement and optimization of drug supply security system is the key of the 'Healthy China 2030' program. In response to the call of national policy, Yuanxin Technology relies on its professional pharmacy network, which covers the whole country and integrates online and offline channels, constantly strengthens the deep layout and explores the way to perfect the drug supply security system. In addition, Yuanxin Technology is also committed to breaking the traditional boundary of medical services, health insurance and other industries, including building and operating online service platforms for hospitals, and designing linkage solutions of healthcare-drug-insurance for industry participants such as pharmaceutical companies and insurers, so that high-quality medical services can reach their target patient population in need more accurately and more rapidly. "

 

About Yuanxin Technology

Beijing Yuanxin Technology Group Co., Ltd ("Yuanxin Technology") is a healthcare company dedicated to delivering value to patients. Established in 2015, the Beijing-based group now employs over 4,000 professionals.

Yuanxin Technology’s business model focuses on patients’ whole medical service cycle. Yuanxin Technology features three pillar services, namely, out-of-hospital comprehensive patient service, supply side empowerment service and innovative healthcare service. All these services are committed to realizing one common goal of building a synergetic healthcare platform that provides comprehensive, personalized and considerate services to patients.

With online and offline channels, Yuanxin Technology integrates hospital and out-of-hospital resources and delivers integrated medical insurance solutions. By breaking the traditional boundary of medical services, pharmaceutical circulation, health insurance, and IT application in healthcare, it establishes a patient-centered digital course management system featuring extensive involvement of hospitals, physicians, pharmaceutical companies and insurers, so as to contribute to the sustainability of the healthcare industry.